Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 35.53%345.03M | 107.68%307.27M | 351.08%273.1M | 64.69%756.65M | 311.65%293.57M | 308.47%254.58M | 102.63%147.96M | -76.05%60.54M | -58.42%459.43M | -71.91%71.32M |
| Operating revenue | 35.53%345.03M | 107.68%307.27M | 351.08%273.1M | 64.69%756.65M | 311.65%293.57M | 308.47%254.58M | 102.63%147.96M | -76.05%60.54M | -58.42%459.43M | -71.91%71.32M |
| Cost of revenue | -28.65%149.62M | 24.23%149.44M | 112.35%157.07M | 49.12%576.69M | 129.88%172.73M | 167.19%209.7M | 48.37%120.29M | -51.35%73.96M | -46.13%386.72M | -52.98%75.14M |
| Gross profit | 335.43%195.41M | 470.57%157.83M | 964.55%116.03M | 147.50%179.95M | 3,258.29%120.84M | 377.70%44.88M | 443.20%27.66M | -113.32%-13.42M | -81.21%72.71M | -104.07%-3.83M |
| Operating expense | 67.29%22.53M | 42.68%16.73M | 72.45%15.1M | 28.38%59.57M | 109.75%25.62M | 7.85%13.47M | 39.25%11.73M | -34.07%8.76M | -38.54%46.4M | -48.87%12.22M |
| Selling and administrative expenses | 56.96%12.56M | 18.41%10.5M | 47.96%10.61M | 29.73%40.6M | 103.20%16.56M | -16.03%8M | 48.15%8.87M | -6.02%7.17M | -29.37%31.3M | -48.64%8.15M |
| -General and administrative expense | 56.96%12.56M | 18.41%10.5M | 47.96%10.61M | 29.73%40.6M | 103.20%16.56M | -16.03%8M | 48.15%8.87M | -6.02%7.17M | -29.37%31.3M | -48.64%8.15M |
| Research and development costs | 66.84%7.85M | 148.75%5.26M | 318.81%3.3M | 80.57%15.72M | 836.33%8.12M | 167.88%4.7M | 46.53%2.11M | -83.05%787K | -65.68%8.71M | -86.98%867K |
| Provision for doubtful accounts | --1.21M | --157K | ---- | --0 | --0 | --0 | --0 | ---- | --1.87M | ---- |
| Other operating expenses | 19.69%912K | 9.54%815K | 49.56%1.19M | -28.26%3.25M | -28.77%946K | -36.61%762K | -25.00%744K | -20.85%797K | -22.26%4.53M | -2.64%1.33M |
| Operating profit | 450.41%172.88M | 785.37%141.1M | 555.15%100.93M | 357.61%120.38M | 693.52%95.21M | 209.64%31.41M | 196.71%15.94M | -125.35%-22.18M | -91.56%26.31M | -122.85%-16.04M |
| Net non-operating interest income (expenses) | 61.07%-1.39M | 141.33%1.02M | 32.73%-2.51M | -2.20%-14.47M | -31.39%-4.71M | 25.74%-3.57M | -15.42%-2.46M | -2.61%-3.73M | 13.15%-14.16M | 36.27%-3.58M |
| Non-operating interest income | 86.68%2.63M | 91.66%4.92M | 47.31%1.81M | -27.34%5.11M | -108.39%-95K | 141,000.00%1.41M | -32.48%2.57M | -41.50%1.23M | -22.65%7.03M | 421.66%1.13M |
| Non-operating interest expense | -19.20%4.02M | -22.47%3.9M | -12.91%4.32M | -7.60%19.58M | -2.16%4.61M | 3.60%4.98M | -15.25%5.03M | -13.53%4.96M | -16.55%21.19M | -19.26%4.72M |
| Other net income (expenses) | -875.91%-18.04M | 69.98%-2.87M | -426.59%-2.65M | 58.82%-12.69M | -483.31%-4.96M | 129.52%2.33M | 72.15%-9.55M | -115.23%-504K | -54.51%-30.82M | -114.17%-851K |
| Gain on sale of security | -213.82%-3.04M | -359.82%-2.04M | -1,590.45%-2.65M | 67.40%-2.56M | -698.45%-4.63M | 144.51%2.67M | 96.21%-443K | -104.74%-157K | 60.62%-7.86M | -109.66%-580K |
| Special income (charges) | -4,248.12%-15M | -139.19%-830K | ---- | 93.93%-1.39M | -30.63%-354K | -336.71%-345K | 98.47%-347K | ---- | ---22.96M | ---271K |
| -Less:Other special charges | 4,248.12%15M | 139.19%830K | ---- | -93.93%1.39M | 30.63%354K | 336.71%345K | -98.47%347K | ---- | --22.96M | --271K |
| -Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1.87M | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---8.74M | --21K | ---- | ---8.76M | ---347K | ---- | ---- |
| Income before tax | 408.69%153.45M | 3,448.73%139.25M | 462.63%95.77M | 599.28%93.22M | 517.74%85.54M | 192.99%30.17M | 107.42%3.92M | -130.30%-26.41M | -106.78%-18.67M | -129.00%-20.48M |
| Income tax | 386.52%11.16M | 161.28%22.91M | 2,804.70%9.79M | 549.65%27.92M | 680.88%17.22M | 237.97%2.29M | 1,929.63%8.77M | -104.26%-362K | -91.38%4.3M | -113.43%-2.97M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 410.51%142.29M | 2,501.80%116.34M | 430.08%85.98M | 384.29%65.3M | 490.12%68.32M | 190.56%27.87M | 90.92%-4.84M | -133.12%-26.05M | -110.19%-22.97M | -136.09%-17.51M |
| Net income continuous operations | 410.51%142.29M | 2,501.80%116.34M | 430.08%85.98M | 384.29%65.3M | 490.12%68.32M | 190.56%27.87M | 90.92%-4.84M | -133.12%-26.05M | -110.19%-22.97M | -136.09%-17.51M |
| Noncontrolling interests | 54.53%1.16M | 100.00%1.06M | 284.86%966K | 1.38%2.57M | 162.44%1.03M | -16.67%750K | 48.74%531K | -71.48%251K | -4.78%2.53M | -70.90%394K |
| Net income attributable to the company | 420.35%141.14M | 2,244.76%115.28M | 423.26%85.01M | 346.01%62.73M | 475.76%67.28M | 185.62%27.12M | 89.99%-5.38M | -133.81%-26.3M | -111.45%-25.5M | -137.96%-17.91M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 420.35%141.14M | 2,244.76%115.28M | 423.26%85.01M | 346.01%62.73M | 475.76%67.28M | 185.62%27.12M | 89.99%-5.38M | -133.81%-26.3M | -111.45%-25.5M | -137.96%-17.91M |
| Diluted earnings per share | 420.47%0.356 | 2,238.24%0.2908 | 423.53%0.2145 | 346.03%0.1582 | 476.27%0.1697 | 185.61%0.0684 | 89.96%-0.0136 | -133.79%-0.0663 | -111.44%-0.0643 | -137.90%-0.0451 |
| Basic earnings per share | 420.47%0.356 | 2,238.24%0.2908 | 423.53%0.2145 | 346.03%0.1582 | 475.69%0.1697 | 185.61%0.0684 | 89.96%-0.0136 | -133.79%-0.0663 | -111.44%-0.0643 | -137.96%-0.0452 |
| Dividend per share | 0 | 0.05 | ||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.